医薬品契約販売の世界市場2016-2026...市場調査レポートについてご紹介

【英文タイトル】Pharma Contract Sales Market 2016-2026 : Revenue Forecasts for Outsourced Detailing, Including Teledetailing and eDetailing, as well as Medical Education and Sample Management Services

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1. Report Overview
1.1 Pharma Contract Sales Overview
1.2 Why You Should Read This Report
1.3 How this Report Delivers
1.4 Main Questions Answered by this Report
1.5 Who is this Report for?
1.6 Research and Analysis Methods
1.7 Frequently Asked Questions (FAQ)
1.8 Some Associated Reports
1.9 About Visiongain

2. Introduction to and Definition of the Pharma Contract Sales Market
2.1 Defining the Market
2.2 What is a CSO?
2.3 What Services do CSOs Provide?
2.4 The Different Marketing Channels Employed by Pharma Companies in 2016
2.5 Growing Trend of Outsourcing in the Overall Pharma Industry
2.6 The Rise in Pharma Contract Sales
2.7 Detailing: Becoming Less Relevant or is it as Important as Ever?
2.7.1 Declining Access to Doctors: Trend Continues in 2016
2.8 Large Cuts in Sales Force in Various Companies
2.9 Companies Cannot Rely Solely Upon Detailing
2.9.1 Trends Driving the Need for New Sales Models

3. Global Pharma Contract Sales Market 2016-2026
3.1 The Market in 2015
3.2 Global Pharma Contract Sales Market 2010-2015
3.2.1 Decent Growth in Past Six Years
3.3 Global Pharma Contract Sales Market 2016-2026
3.4 The Factors that will Drive Growth in this Market: Advantages of Outsourcing Pharma Sales
3.4.1 Cost and Flexibility
3.4.2 New Technologies and Sales Models
3.4.3 Emerging Markets and Mature Brands
3.4.4 Biosimilars
3.4.5 Account Management, Medical Education and Patient Support Services
3.4.6 Market Access Complexities Provide its Own Opportunities for CSOs
3.4.7 New Drug Launches
3.4.8 Summary
3.5 The Factors that will Restrain Growth in this Market: Disadvantages of Outsourcing Pharma Sales
3.6 Leading Therapeutic Submarkets for Pharma Contract Sales, Forecast 2016-2026
3.7 How Will the Therapeutic Composition of the Market Change Between now and 2026?
3.8 Contract Sales for Cardiovascular Drugs
3.8.1 Current Status
3.8.2 Recent Cardiovascular Drug Patent Expiries and FDA Approvals
3.8.3 Cardiovascular and Cerebrovascular Conditions are the World’s Most Fatal Diseases
3.8.4 Contract Sales for Cardiovascular Drugs: Submarket Forecast 2016-2026
3.9 Contract Sales for Metabolic Disorder Drugs
3.9.1 Current Status
3.9.2 430 Million People Expected to be Diagnosed with Diabetes by 2030
3.9.3 Contract Sales for Metabolic Disorders: Submarket Forecast 2016-2026
3.10 Contract Sales for Oncology Drugs
3.10.1 Current Status
3.10.2 Patent Expiries and Recent Approvals
3.10.3 Contract Sales for Oncology Drugs Forecast 2016-2026

4. Leading Service Sectors of the Pharma Contract Sales Market 2016-2026
4.1 The Leading Services
4.1.1 Leading Service Sectors of the Market, Forecast 2016-2026
4.1.2 How Will the Service Composition over the Market Change over the Next Ten Years?
4.2 Contract Detailing Submarket
4.2.1 Are we in the Midst of a Turnaround in Sales Rep Numbers in the Overall Pharma Industry?
4.2.2 What are the Trends in Sales Reps Employed by CSOs?
4.2.3 Detailing Services Offered by CSOs
4.2.4 CSOs will be Impacted by Declining Physician Access as Much as In-House Reps
4.2.5 Contract Detailing Submarket Forecast 2016-2026
4.2.6 Drivers and Restraints for this Dominant Service Submarket
4.3 Contract Non-Personal Promotion
4.3.1 The Benefits for both Pharma Companies and Doctors
4.3.2 Contract Non-Personal Promotion Submarket Forecast 2016-2026
4.3.3 Drivers and Restraints for Contract Non-Personal Promotion: Multichannel Marketing in the 21st Century
4.3.4 Further Sub-Sectors Within the Contract Non-Personal Promotion Submarket: Teledetailing and EDetailing
4.3.4.1 Contract Teledetailing Submarket: Current Status
4.3.4.2 Contract Teledetailing Submarket Forecast 2016-2026
4.3.4.3 Drivers and Restraints for Outsourced Teledetailing
4.3.4.4 Contract eDetailing Current Status
4.3.4.5 Contract eDetailing Submarket Forecast 2016-2026
4.3.4.6 Drivers and Restraints for Outsourced eDetailing
4.4 Medical Education Services Submarket Current Status
4.4.1 Medical Education Services Submarket Forecast 2016-2026
4.4.2 Medical Education Services Drivers and Restraints
4.5 Sample Management Services Submarket: Current Status
4.5.1 Sample Management Services Submarket Forecast 2016-2026
4.5.2 Drivers and Restraints for the Sample Management Services Submarket
4.5.3 J. Knipper and Company Inc: A US Leader in Sample Management Services
4.5.3.1 Company Acquires Sample Management Divisions from Leading CSOs 2010-2014
4.5.3.2 Construction Underway for New State of the Art Distribution Centre
4.5.3.3 New Multi-Million Dollar Contact Centre Opened
4.5.3.4 New Technologies to Drive Growth Over Next Ten Years

5. Leading National Markets for Pharma Contract Sales: Regulatory and Commercial Outlook 2016-2026
5.1 Current Leading National Markets
5.2 Leading Regional Markets Forecast 2016-2026
5.3 How will the Regional Composition of the Market Change between now and 2026?
5.4 Pharma Sales Regulatory Developments
5.4.1 Physician Payment Legislation in the US, Europe and Japan
5.4.1.1 The Physician Payment Sunshine Act (PPSA)
5.4.1.2 Proposed Bill to Close a Large Loophole in the PPSA, Could Come into Effect in 2017
5.4.1.3 Physician Payments in France: Increased Scrutiny
5.4.2 Domestic and International Concerns over Bribery: Recent Legislation in the US and UK
5.4.2.1 Promotional Products in the EU: New Rules
5.4.3 New Market Access Requirements in EU5 Countries
5.4.3.1 AMNOG: Stricter Pricing for Drugs in Germany
5.4.3.2 AMNOG: Has Reduced Prices of Top Sellers by 23%
5.4.3.3 Healthcare Reform in France: Pricing and Reimbursements have been set to Change for a While, is 2016 the Year it Finally Happens?
5.4.3.4 PCTs Replaced by CCGs in the UK
5.4.3.5 Pricing in the UK: Contentious Issue
5.4.4 Overtime for Sales Reps in the US: Rule Clarifications
5.5 US Pharma Contract Sales Market
5.5.1 Has Come a Long Way
5.5.2 Pharma Sales Regulation in the US
5.5.3 Trends in 2015 as Witnessed by a Large CSO
5.5.4 US Pharma Contract Sales Market Forecast 2016-2026
5.6 EU5 Pharma Contract Sales Market
5.6.1 Regulating Pharma Sales in the EU
5.6.2 Overall EU5 Pharma Contract Sales Market Forecast 2016-2026
5.6.3 UK Pharma Contract Sales Market Forecast 2016-2026
5.6.4 German Pharma Contract Sales Market Forecast 2016-2026
5.6.5 French Pharma Contract Sales Market Forecast 2016-2026
5.6.6 Italian Pharma Contract Sales Market Forecast 2016-2026
5.6.7 Spanish Pharma Contract Sales Market Forecast 2016-2026
5.7 Japanese Pharma Contract Sales Market
5.7.1 Regulation
5.7.2 Trends in 2015 as Witnessed by a Large CSO
5.7.3 Current Market Landscape
5.7.4 Japanese Pharma Contract Sales Market Forecast 2016-2026

6. Leading Emerging Markets for Pharma Contract Sales: Regulatory and Commercial Outlook 2016-2026
6.1 Pharma Contract Sales in Leading Emerging Markets in 2015
6.2 BRIC Pharma Contract Sales Markets Forecast 2016-2026
6.3 Chinese Pharma Contract Sales Market
6.3.1 Current Pharma Contract Sales Landscape in China
6.3.2 Rising In-House and Outsourced Sales Numbers
6.3.3 Concerns over Bribery
6.3.4 Chinese Pharma Contract Sales Market Forecast 2016-2026
6.4 Indian Pharma Contract Sales Market
6.4.1 Current Pharma Contract Landscape in India
6.4.2 Government and Regulatory Guidelines for Interactions Between Healthcare Professionals and Pharma Companies
6.4.3 Indian Pharma Contract Sales Market Forecast 2016-2026
6.5 Brazilian Pharma Contract Sales Market
6.5.1 Current Pharma Contract Sales Landscape in Brazil
6.5.2 State Payment Rules and Online Marketing Rules for Prescription Drugs
6.5.3 Brazilian Pharma Contract Sales Market Forecast 2016-2026
6.6 Russian Pharma Contract Sales Market
6.6.1 Current Pharma Contract Sales Landscape in Russia
6.6.2 New State Procurement Rules for Drugs Introduced in 2013
6.6.3 Tougher Rules on Interactions Between Doctors and Sales Reps in Russia
6.6.4 Russian Pharma Contract Sales Market Forecast 2016-2026

7. Pharma Contract Sales: Industry and Market Trends 2016-2026
7.1 Strengths and Weaknesses for the Global Pharma Contract Sales Market 2016-2026
7.2 Opportunities and Threats for the Global Pharma Contract Sales Market 2016-2026
7.3 Pharma Contract Sales Market: STEP Analysis 2016-2026
7.3.1 Social Factors Affecting Pharma Contract Sales to 2026
7.3.1.1 The Role of Ethics in Pharma Sales
7.4 Technological Developments to Improve Sales Strategies
7.4.1 Advantages of Using Tablets and Smartphones for Detailing
7.4.1.1 CSOs Need to Maximise on the Benefits of New Technologies
7.4.2 Closed Loop Marketing (CLM)
7.4.3 Customer Relationship Management (CRM)
7.4.4 The Advantages of Cloud Computing in Pharma Contract Sales
7.4.5 Does Big Data Have a Role in Pharma Sales?
7.4.6 Social Media in Relation to Pharma Sales
7.4.6.1 FDA Releases Long-Awaited Guidance on the use of Social Media
7.4.6.2 Pharma Industry is not Using Social Media to its Full Potential, but it Offers many Benefits
7.5 Economic Pressures are Limiting Healthcare and Marketing Budgets
7.6 Political Issues: Stricter Regulations for Pharma Sales around the World
7.7 Trends in Pharma Contract Sales 2016-2026
7.7.1 Cuts to In-House Sales Staff will Continue 2016-2026
7.7.2 There will be in an Increase in Strategic Partnering in Order to Provide Long-Term Revenue Growth
7.7.3 Leading CSOs have Consolidated, and will Continue to Consolidate, in Order to Increase Market Penetration
7.7.4 CSOs and Pharma Clients Alike Need to Stay Vigilant about the Risks of Outsourcing Pharma Sales
7.8 Drug Development Trends Affecting Pharma Sales 2016-2026
7.8.1 How will Orphan Drug Diseases Influence Pharma Contract Sales?
7.8.2 Promotion for Biosimilar Drugs over the Next Ten Years
7.8.3 There will be Greater Demand for Specialty Medicines
7.8.4 Emerging National Markets are Becoming Increasingly Important
7.9 Sales Models Need to Evolve with the Times
7.9.1 Why are Sales Reps Struggling for Access?
7.9.1.1 One way to Fight Against Reduced Access is to Target the System as a Whole
7.9.1.2 Multichannel Marketing to Overcome Problems of Access
7.9.2 Key Account Management (KAM)
7.9.3 Silos in Sales and Marketing
7.9.4 The Use of KOLs in Pharma Sales
7.10 Market Access
7.10.1 Emerging Stakeholders in Pharma Sales
7.10.2 The Rise of ACOs
7.10.2.1 20% of US Hospitals were Part of an ACO in 2014
7.10.3 Market Access in the EU Over the Next Ten Years
7.10.4 CSOs and Market Access Consulting
7.11 Summary: Main Trends Shaping Pharma Contract Sales 2016-2026

8. Leading Contract Sales Organisations (CSOs)
8.1 Current Industry Landscape
8.2 Quintiles
8.2.1 World Market Leader for Contract Sales and Market Access
8.2.2 New Services and Strategic Partnerships
8.2.3 Quintiles Integrated Health Services Segment Performance 2010-2015
8.2.4 Outlook for Quintiles Contract Sales to 2026
8.3 UDG Healthcare
8.3.1 Global Service Provider with Various Business Units
8.3.2 Geographic and Service Growth Through Acquisitions
8.3.3 Joint Venture with CMIC
8.3.4 UDG Healthcare Financial Performance 2010-2015 and Beyond
8.4 inVentiv Health
8.4.1 Combined CRO and CCO
8.4.2 Global Structure
8.4.3 inVentiv Health Presence in US, EU and Asia
8.4.4 Possible $500m IPO in the Near Future
8.4.5 inVentiv Health Contract Sales Outlook to 2026
8.5 Publicis Healthcare Communications Group
8.5.1 PHCG Purchases PDI Commercial Services Business
8.5.1.1 PDI Prior to Acquisition: Broad Service Portfolio, Resources which PHCG now Acquires
8.5.1.2 PDI Past Financial Performance
8.5.2 Publicis Touchpoint Solutions
8.5.2.1 New Services in Recent Years, and Tardis Medical to be Aligned with the Company
8.6 OnCall, LLC
8.6.1 Range of Services
8.6.2 Contracts with Promius Pharma
8.7 Marvecs
8.7.1 A Local Leader in Germany
8.7.2 New Services Added in Recent Years: Sales 3.0
8.8 Sofip: Contract Sales for the French Submarket
8.9 CMIC
8.9.1 CSO Business in Japan Since 2000
8.10 Leading Players in China are not Just CSOs

9. Research Interviews
9.1 Walter R. Dewees, Executive Vice-President, OnCall LLC
9.1.1 OnCall, LLC
9.1.2 Promotional Outsourcing in the US
9.1.3 Increasing Engagement via Technology-Enabled Multi-Channels
9.1.4 Growing Medical Science Liaison Function
9.1.5 Risk-Sharing Agreement
9.2 Tony Swift, Managing Director, Apodi
9.2.1 Apodi
9.2.2 Market Access Challenges in the UK
9.2.3 CSOs Can Promote Partnership Between Pharma and the NHS
9.2.4 Value Propositions Offered by CSOs
9.3 Holger C.W. Fürstenberg, Founder and Managing Director, Hilver
9.3.1 Hilver
9.3.2 Integrating CLM and Digital Strategy Remains a Challenge
9.3.3 CLM Implementation – Bridging Sales and Marketing
9.3.4 Company Culture is yet to Fully Embrace Digital Toolsets
9.3.5 Digital Tools Facilitate Unparalleled Customer Service

10. Conclusions of the Research and Analysis
10.1 The Global Pharma Contract Sales Market in 2015
10.1.1 Which Sectors Generated the Most Revenues in 2015?
10.1.2 Spending on Contract Sales is Highest in the US and EU
10.2 Outlook for the Pharma Contract Sales Market 2016-2026
10.2.1 Growth Trends for the Leading Submarkets 2016-2026
10.2.1.1 Therapeutic Sector Growth 2016-2026
10.3 Commercial Drivers for Pharma Contract Sales


【レポート販売概要】

■ タイトル:医薬品契約販売の世界市場2016-2026
■ 英文:Pharma Contract Sales Market 2016-2026 : Revenue Forecasts for Outsourced Detailing, Including Teledetailing and eDetailing, as well as Medical Education and Sample Management Services
■ 発行日:2016年3月
■ 調査会社:visiongain
■ 商品コード:VGAIN6041537
■ 調査対象地域:グローバル
  • 狭帯域IoT(NB-IoT)企業アプリケーションの世界市場予測:スマートガバナンス、スマートメータリング、スマートホーム、スマートアセットトラッキング
    MarketsandMarkets forecasts the global NB–IoT enterprise application market size to grow from USD 320.5 Million in 2017 to USD 8,221.3 Million by 2022, at a Compound Annual Growth Rate (CAGR) of 91.3% from 2017 to 2022. Growing demand for Low-Power Wide Area Network (LPWAN) use cases across verticals, high deployment flexibility with GSM, WCDMA, or LTE, extended coverage and long battery life, low …
  • オトスコープ(耳鏡)の世界市場2018-2022
    About otoscopes Otoscopes are a medical device useful in assisting the physician in making a physical diagnosis of ear-related ailments such as infection, irritation, ear pain, ear discharge, and redness. Technavio’s analysts forecast the Global otoscopes market to grow at a CAGR of 4.02% during the period 2018-2022. Covered in this report The report covers the present scenario and the growth pros …
  • 磁気分離装置の世界市場2017-2021
    About Magnetic Separation EquipmentMagnetic separation is a process in which a magnetically susceptible material is extracted from a mixture using magnetic force. Magnetic separation equipment is used in various applications across mining and aggregates industry; light industries; and recycling, water and wastewater industries to separate magnetic material from the non-magnetic or less magnetic ma …
  • けいそう土の世界市場
    Diatomaceous Earth (CAS 61790-53-2) Market Research Report 2014 presents comprehensive data on diatomaceous earth markets globally and regionally (Europe, Asia, North America etc.) The report includes diatomaceous earth description, covers its application areas and related patterns. It overviews diatomaceous earth market, names diatomaceous earth producers and indicates its suppliers. Besides, the …
  • エポキシ硬化剤の世界市場予測(~2022):アミン系エポキシ硬化剤、酸無水物系エポキシ硬化剤
    The epoxy curing agents market is projected to reach USD 5.02 Billion by 2022, at a CAGR of 6.84% from 2017 to 2022. The growth of the market can be attributed to the expansion of the construction industry, increasing urban population, and growth of the composite industry. Based on application, the coatings segment is projected to lead the epoxy curing agents market, while the wind energy segment …
  • DeRoyal Industries, Inc.:市場シェア分析
    DeRoyal Industries, Inc. Market Share Analysis Summary GlobalData’s new report, “DeRoyal Industries, Inc. Market Share Analysis” provides in-depth information on DeRoyal Industries, Inc.’s market position in the different medical equipment markets it operates in. The report provides DeRoyal Industries, Inc. market share information in two key market categories – Orthopedic Braces and Supports and …
  • 世界のITロボット自動化市場
    IT robotic automation gives enhanced adaptability to effectively increasing or diminishing production levels at low expense. In businesses where interest for items and administration is similar to the case with financial items, enhanced versatility offered by robotic automation serves to adequately scale throughput at a settled level of value and known administration levels. IT robotic automation …
  • IoT(モノのインターネット)の世界市場:リアルタイムストリーミング分析、セキュリティ、データ管理、遠隔モニタリング、ネットワーク帯域管理
    MarketsandMarkets forecasts the Internet of Things market size to grow from USD 157.05 Billion in 2016 to USD 661.74 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 33.3% from 2016 to 2021. The increasing number of connected devices and the proliferation of smartphones have contributed significantly to the rise of IoT. Rising adoption of cloud platforms, development of cheaper and smar …
  • 医療用チューブの世界市場予測(~2021年):PVC、ポリオレフィン、TPE、TPU、シリコンチューブ
    The medical tubing market size is projected to witness a CAGR of 8.0% from 2016 to reach a market size of USD 5.85 Billion, by 2021. The market is mainly driven by minimally invasive surgery. Another major factor that is expected to bring momentum to this market are increasing aging population, especially in developing countries, and the rising awareness about healthcare and the government initiat …
  • オーストラリアのビチューメン及びアスファルト市場:貿易(輸入、輸出)動向
    This market research report examines the foreign trade of Australia and its perspectives on the global market for Bitumen and asphalt, natural. The report will be of considerable interest primarily to relevant strategic planners, senior company officials and importers/exporters, since it features invaluable information on Bitumen and asphalt, natural export/import operations in Australia. The 2002 …
  • 世界の自動車用コネクター市場2015
    The Global Automotive Connectors Industry Report 2015 is a professional and in-depth study on the current state of the Automotive Connectors industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Automotive Connectors market analysis is provided for the international markets including development trends, …
  • 無菌処理の世界市場予測(~2022):装置別(加工&包装)、用途別、パッケージング別、地域別
    The global aseptic processing market is classified in two parts, namely, packaging market and equipment market. The equipment market is projected to reach USD 12.24 Billion by 2022, growing at a CAGR of 3.8% from 2017, in terms of value. The packaging market is projected to reach USD 77.25 Billion by 2022, growing at a CAGR of 10.6% from 2017, in terms of value. Factors such as increase in urban p …
  • 世界のスポーツ装備(用品)動向(2012-2016)
    TechNavio's analysts forecast the Global Sports Equipment market to grow at a CAGR of 2.38 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing participation in sporting activities. The Global Sports Equipment market has also been witnessing the increasing use of carbon fiber in sports equipment. However, the increasing availability of coun …
  • 世界のWebアプリケーションファイアウォール市場動向(2012-2016)
    TechNavio's analysts forecast the Global Web Application Firewall market to grow at a CAGR of 18.34 percent over the period 2012-2016. One of the key factors contributing to this market growth is the need to meet PCI DSS regulatory standards. The Global Web Application Firewall market has also been witnessing the integration of security functionalities. However, the increase in false-positive risk …
  • ハーブサプリメントの世界市場2016-2020
    About Herbal Supplements A type of dietary supplement made of herbs, or when parts of herbs are used in supplements for scent, flavor, or potential therapeutic properties. In dietary supplements, the demand for herbal supplements is growing because of the growing demand for natural products. Technavio’s analysts forecast the global herbal supplements market to grow at a CAGR of 6.29% during the pe …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。